Peginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVR

NCT00532701 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

880

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: Peg-IFN + WB RBV for 16 weeks
DRUG: Peg-IFN + LD RBV for 16 weeks
DRUG: Peg-IFN + WB RBV for 24 weeks
DRUG: Peg-IFN + WB RBV for 48 weeks
DRUG: Peg-IFN + LD RBV for 24 weeks

Sponsor

National Taiwan University Hospital

Collaborators

[object Object]
[object Object]